A clinical trial of flufenamic acid in the treatment of rheumatoid arthritis.
D000006:Abdomen, Acute / Q000139:chemically induced; D000082:Acetaminophen / Q000627:therapeutic use; D000535:Aluminum / Q000627:therapeutic use; D000893:Anti-Inflammatory Agents / Q000627:therapeutic use*; D001172:Arthritis, Rheumatoid / Q000188:drug therapy*; D001219:Aspartate Aminotransferases / Q000097:blood; D001241:Aspirin / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D003061:Codeine / Q000627:therapeutic use; D003967:Diarrhea / Q000139:chemically induced; D005260:Female; D005439:Flufenamic Acid / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D005461:Fluorine / Q000627:therapeutic use; D006801:Humans; D008528:Mefenamic Acid / Q000627:therapeutic use; D010653:Phenylbutazone / Q000627:therapeutic use; D010710:Phosphates / Q000627:therapeutic use; D010919:Placebos; D012459:Salicylates / Q000627:therapeutic use; D013280:Stomatitis / Q000139:chemically induced; D062367:ortho-Aminobenzoates / Q000627:therapeutic use*
D000893:Anti-Inflammatory Agents; D010710:Phosphates; D010919:Placebos; D012459:Salicylates; D062367:ortho-Aminobenzoates; D005461:Fluorine; D000082:Acetaminophen; D008528:Mefenamic Acid; D005439:Flufenamic Acid; D000535:Aluminum; D001219:Aspartate Aminotransferases; D010653:Phenylbutazone; D001241:Aspirin; D003061:Codeine